4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-25-000957
Options or other derivatives
- Chief Chemistry Officer acquired 175,000 shares (grant or award)
From the SEC's structured data for this filing
Prelude Therapeutics Inc Filed Acc 0001562180-25-000957
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…